CHR. OLESEN SYNTHESIS A/S: Financial statements 2013
CVR: 33964870
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
CHR. OLESEN SYNTHESIS A/S (CVR 33964870) has filed annual accounts for 2013. In 2013, the company reported a gross profit of EUR -85 and a net result of EUR -1,455,185 compared with DKK -1,636,018 the year before. Equity in the 2013 report amounted to EUR -2,620,140.
- Gross Profit
- EUR -85
- Profit/Loss
- EUR -1,455,185
- Equity
- EUR -2,620,140
- Total Assets
- EUR 3,724,948
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -85 EUR | -1.5M EUR | -2.6M EUR | - |
| 2012 | - | -934K | -1.6M | -1.2M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
CHR. OLESEN SYNTHESIS A/S has published its annual report for 2012. Gross profit came to DKK -934,374, and the net result was DKK -1,636,018.
About CHR. OLESEN SYNTHESIS A/S
CHR. OLESEN SYNTHESIS A/S is a Danish company of the type Aktieselskab based in Hvidovre, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Thomas Michael Moestrup. The board consists of Jean-Francois Hilaire (chair), Joseph Nivaro and Thomas Michael Moestrup. The company is owned by Samfara/Bering Bidco Limited. The company has 97 employees (2026). In 2025, the company reported a gross profit of EUR 6,958,825 and a net result of EUR -2,299,046 compared with EUR 7,391,800 the year before. Equity in the 2025 report amounted to EUR -9,489,900.
